ArticleCancer2019

Will deeper characterization of the landscape of immune checkpoint molecules in acute myeloid leukemia bone marrow lead to improved therapeutic targeting?

Esten N Vandsemb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.